effect
separ
viral
infect
respiratori
tract
pulmonari
function
evalu
prospect
eightyear
period
patient
chronic
obstruct
pulmonari
diseas
eight
normal
subject
viral
infect
associ
small
acut
declin
forc
vital
capac
andor
isec
forc
expiratori
volum
ml
declin
detect
period
infect
greatest
abnorm
pulmonari
function
follow
infect
influenza
viru
mean
acut
chang
isec
forc
expiratori
volum
ml
significantli
greater
expect
ml
p
smaller
statist
insignific
declin
follow
infect
parainfluenza
viru
rhinoviru
adenoviru
respiratori
syncyti
viru
chang
detect
infect
coronaviru
herp
simplex
viru
mycoplasma
pneumonia
haemophilu
influenza
longterm
effect
influenza
viral
infect
cours
chronic
obstruct
pulmonari
diseas
detect
studi
popul
hypothesi
viral
infect
respiratori
tract
may
contribut
progress
deterior
airway
function
patient
chronic
bronchiti
emphysema
chronic
obstruct
pulmonari
diseas
copd
intrigu
investig
sever
year
evid
support
hypothesi
includ
welldocu
associ
viral
infect
acut
exacerb
bronchiti
patient
copd
well
recent
report
transient
alter
function
small
airway
may
occur
normal
adult
acut
viral
infect
respiratori
tract
effect
separ
viral
infect
respiratori
tract
pulmonari
function
evalu
prospect
eightyear
period
patient
chronic
obstruct
pulmonari
diseas
eight
normal
subject
viral
infect
associ
small
acut
declin
forc
vital
capac
andor
isec
forc
expiratori
volum
ml
declin
detect
period
infect
greatest
abnorm
pulmonari
function
follow
infect
influenza
viru
mean
acut
chang
isec
forc
expiratori
volum
ml
significantli
greater
expect
ml
p
smaller
statist
insignific
declin
follow
infect
parainfluenza
viru
rhinoviru
adenoviru
respiratori
syncyti
viru
chang
detect
infect
coronaviru
herp
simplex
viru
mycoplasma
pneumonia
haemophilu
influenza
longterm
effect
influenza
viral
infect
cours
chronic
obstruct
pulmonari
diseas
detect
studi
popul
hypothesi
viral
infect
respiratori
tract
may
contribut
progress
deterior
airway
function
patient
chronic
bronchiti
emphysema
chronic
obstruct
pulmonari
diseas
copd
intrigu
investig
sever
year
evid
support
hypothesi
includ
welldocu
associ
viral
infect
acut
exacerb
bronchiti
patient
copd
well
recent
report
transient
alter
function
small
airway
may
occur
normal
adult
acut
viral
infect
respiratori
tract
recent
studi
live
attenu
vaccin
influenza
viru
zeck
et
al
report
patient
copd
like
develop
transient
deterior
pulmonari
function
infect
normal
adult
unfortun
except
limit
inconclus
studi
stenhous
adequ
prospect
studi
associ
natur
viral
infect
chang
pulmonari
function
patient
copd
studi
associ
infect
deterior
pulmonari
function
mani
investig
equat
infect
clinic
exacerb
failur
defin
adequ
specif
infecti
etiolog
exacerb
may
explain
gener
conflict
result
studi
leeder
specul
exacerb
associ
certain
viral
infect
influenza
might
consider
effect
pulmonari
function
would
exacerb
associ
allerg
reaction
environment
factor
initi
longterm
prospect
studi
effect
bacteri
viral
mycoplasm
infect
clinic
cours
rate
deterior
pulmonari
function
patient
copd
acut
longterm
effect
separ
viral
infect
respiratori
tract
forc
vital
capac
fvc
isec
forc
expiratori
volum
fev
assess
report
studi
popul
studi
popul
consist
subject
observ
mean
year
rang
two
eight
year
period
eight
subject
consid
normal
function
evid
obstruct
pulmonari
diseas
upon
entri
studi
fevfvc
ratio
remain
histori
consist
clinic
diagnosi
chronic
bronchiti
andor
mild
air
flow
obstruct
detect
reduc
rate
midexpiratori
flow
ten
subject
whose
primari
diagnosi
asthma
exclud
analys
wide
variabl
perform
pulmonari
function
test
detail
descript
criteria
use
select
studi
patient
clinic
characterist
previous
publish
patient
examin
clinic
everi
three
month
mean
visitsyear
question
regard
recent
acut
respiratori
ill
immun
antimicrobi
therapi
diseas
statu
clinic
visit
pulmonari
function
assess
spirometri
serum
obtain
antibodi
studi
throat
swab
nasal
wash
sputum
specimen
collect
isol
virus
mycoplasma
bacteria
regular
schedul
surveil
augment
weekli
telephon
call
subject
instruct
call
investig
first
sign
acut
respiratori
ill
ill
occur
nurs
visit
home
obtain
sampl
respiratori
tract
secret
cultur
pulmonari
junction
test
spirometri
perform
administr
aerosol
bronchodil
bronkomet
breon
lab
new
york
ny
use
establish
procedur
determin
fvc
fev
made
largest
fvc
two
three
spirogram
data
taken
administr
bronchodil
analyz
valu
repres
patient
maxim
valu
given
day
addit
significantli
less
variabl
long
period
data
taken
administr
bronchodil
individu
subject
p
sign
rank
test
data
screen
presenc
spirometr
valu
sd
regress
line
individu
subject
suggest
fletcher
et
al
valu
outsid
rang
examin
procedur
error
miscalcul
evid
inconsist
individu
subject
clinic
cours
data
obvious
error
discard
fewer
measur
discard
procedur
microbiolog
studi
throat
swab
place
viral
transport
medium
consist
veal
infus
broth
difco
detroit
mich
contain
bovin
serum
albumin
penicillin
unitsml
streptomycin
ugml
secret
present
upper
nasopharynx
collect
viral
cultur
wash
nostril
ml
nacl
mix
wash
equal
volum
viral
transport
medium
avail
sputum
sampl
also
obtain
bacteri
viral
cultur
sputum
sampl
specimen
viral
cultur
kept
c
inocul
onto
appropri
media
tissu
cultur
cell
inocul
specimen
gener
complet
within
hr
collect
sputum
throat
nasal
wash
specimen
inocul
onto
human
embryon
lung
cell
cultur
isol
rhinovirus
herp
simplex
virus
cell
cultur
incub
c
rollertub
apparatu
examin
daili
evid
viral
cpe
isol
cultur
exhibit
typic
cpe
character
test
acid
labil
chloroform
sensit
test
presenc
cf
antibodi
respiratori
virus
mycoplasma
pneumonia
haemophilu
influenza
perform
microtit
procedur
adenoviru
antigen
parainfluenza
viru
antigen
type
guinea
pig
complement
obtain
flow
laboratori
inglewood
calif
solubl
cf
antigen
influenza
type
b
respiratori
syncyti
viru
pneumonia
obtain
microbiolog
associ
lo
angel
calif
coronaviru
antigen
prepar
infect
cell
use
techniqu
kapikian
et
al
h
influenza
group
cf
antigen
prepar
american
type
cultur
collect
strain
techniqu
tuneval
hal
antigen
prepar
test
presenc
antibodi
coronaviru
perform
techniqu
kay
dowdl
known
crossreact
parainfluenza
viru
type
antigen
produc
highest
rise
antibodi
titer
design
infect
agent
purpos
data
analysi
date
infect
rhinoviru
herp
simplex
viru
consid
date
isol
viru
regardless
presenc
absenc
ill
infect
virus
pneumonia
h
influenza
base
demonstr
fourfold
greater
rise
antibodi
titer
consecut
sera
serolog
rise
associ
acut
respiratori
ill
interv
take
sera
includ
analysi
date
patient
first
note
symptom
chosen
date
viral
bacteri
infect
two
ill
occur
interv
consecut
sera
ill
compat
type
viral
infect
chosen
exampl
rise
titer
antibodi
influenza
viru
would
associ
febril
lower
respiratori
tract
ill
januari
rather
mild
upper
respiratori
tract
ill
march
statist
method
empir
random
mont
carlo
method
use
determin
whether
chang
pulmonari
function
event
case
infect
influenza
viru
could
explain
chanc
variat
explain
method
use
analysi
use
exampl
interest
compar
mean
fev
sixmonth
period
influenza
viral
infect
event
mean
fev
threemonth
period
immedi
thereaft
patient
observ
exist
mean
valu
test
conduct
sixmonth
period
event
mean
test
done
threemonth
period
event
calcul
real
differ
patient
given
mean
minu
mean
one
event
occur
patient
mean
obtain
take
mean
mean
event
mean
mean
event
mean
real
differ
dr
fev
calcul
patient
real
differ
follow
influenza
viral
infect
determin
statist
signific
dr
chose
compar
simul
distribut
either
ttest
sign
rank
test
could
use
test
hypothesi
nochang
declin
expect
time
test
use
simul
expect
chang
deriv
pseudoev
patient
creat
random
univac
comput
sperri
univac
st
paul
minn
patient
given
number
real
influenza
viral
infect
number
simul
random
pseudoinfect
creat
patient
process
perform
simul
infect
real
infect
patient
mean
fev
mean
simul
infect
mean
fev
mean
simul
infect
determin
simul
differ
patient
given
mean
minu
mean
valu
averag
patient
influenza
viral
infect
requir
fev
observ
done
real
data
mean
simul
differ
calcul
singl
ds
enough
make
comparison
valu
given
real
data
dr
conceptu
whole
simul
process
could
repeat
obtain
million
great
number
b
valu
could
put
ascend
order
count
mani
valu
dr
one
could
precis
determin
likelihood
obtain
aberr
valu
dr
fact
dr
came
random
distribut
cost
per
simul
balanc
need
precis
determin
actual
number
simul
chosen
simul
number
set
simul
repeat
stabil
result
observ
use
comput
capabl
make
repeat
calcul
b
differ
random
number
one
may
calcul
empir
p
valu
dr
null
hypothesi
dri
random
distribut
p
valu
onetail
proport
valuesdr
empir
estim
p
valu
obtain
calcul
valu
order
includ
dr
neg
posit
valu
thu
greatest
declin
pulmonari
function
valu
given
real
data
p
next
greatest
given
dr
p
forth
make
simul
feasibl
lend
stabil
observ
patient
five
observ
pulmonari
function
least
two
year
includ
add
stabil
infect
elimin
analysi
distribut
simul
differ
contain
differ
valu
facilit
comput
data
correspond
believ
usual
happen
whenev
infect
pulmonari
function
observ
occur
date
assum
infect
preced
observ
period
three
month
immedi
event
also
interest
comparison
use
mean
six
month
event
also
made
mean
three
six
month
six
nine
month
forth
includ
month
event
acut
respiratori
ill
associ
influenza
viral
infect
occas
individu
data
individu
elimin
analysi
insuffici
data
pulmonari
function
test
permit
statist
evalu
addit
normal
subject
asthma
exclud
result
would
reflect
popul
chronic
bronchiti
andor
emphysema
chang
fvc
fev
follow
influenza
viral
infect
occas
individu
present
figur
point
graph
repres
differ
real
simul
valu
dr
differ
mean
test
done
sixmonth
interv
viral
infect
mean
test
done
indic
threemonth
interv
viral
infect
mean
real
chang
fev
first
day
influenza
ml
dr
significantli
greater
calcul
mean
simul
chang
ml
p
real
chang
eight
infect
analyz
interv
rang
ml
ml
seven
eight
infect
real
declin
fev
greater
simul
valu
six
infect
real
declin
ml
advers
effect
influenza
viral
infect
fev
appear
transient
differ
real
simul
valu
threeto
sixmonth
interv
infect
ml
test
done
six
nine
month
infect
reveal
differ
real
simul
valu
chang
fvc
infect
similar
magnitud
tend
parallel
chang
fev
howev
variabl
chang
statisti
comparison
mean
real
differ
dr
fev
fvc
test
done
month
interv
influenza
threemonth
interv
influenza
viral
infect
done
subject
classifi
accord
alpha
jantitrypsin
phenotyp
degre
airway
reactiv
defin
fev
bronchodilatorifev
bronchodil
x
smoke
statu
tabl
three
normal
subject
includ
analysi
provid
addit
number
comparison
mean
chang
three
fev
ml
fvc
ml
exclus
analysi
qualit
alter
result
subject
normal
alphavantitrypsin
phenotyp
smaller
chang
fev
greater
chang
fvc
subject
heterozyg
defici
subject
high
airway
reactiv
defin
improv
bronchodil
greater
declin
fev
subject
low
airway
reactiv
wherea
opposit
true
fvc
consist
associ
seen
smoke
individu
smoke
throughout
studi
greater
declin
fvc
fev
influenza
never
smoke
former
smoker
instanc
differ
patient
group
signific
analyz
analysi
varianc
kruskalw
test
complex
lung
diseas
various
term
chronic
bronchiti
emphysema
copd
repres
import
caus
morbid
mortal
tabl
real
minu
simul
valu
fir
os
mean
differ
lsec
forc
expiratori
volum
fev
forc
vital
capac
fvc
sixmonth
interv
infect
threemonth
interv
infect
accord
type
infect
iti
smoke
air
pollut
lung
infect
variou
host
suscept
factor
consid
possibl
caus
rel
import
still
debat
opinion
investig
differ
defin
popul
studi
identifi
lung
infect
pulmonari
function
test
use
statist
analysi
particularli
difficult
must
includ
consider
effect
variabl
intermitt
constant
factor
throughout
diseas
cours
year
difficulti
consid
follow
discuss
find
spirometr
test
pulmonari
function
ideal
monitor
natur
histori
capo
tager
et
al
shown
patient
capo
variabl
fev
consecut
test
day
may
exceed
yearli
rate
chang
fletcher
et
al
estim
least
observ
rate
declin
fev
eightyear
period
could
account
variabl
test
analyz
data
taken
administr
bronchodil
valu
less
variabl
also
interest
longterm
effect
viral
infect
wish
reduc
variabl
induc
acut
bronchospast
effect
viral
infect
nevertheless
rel
insensit
spirometr
test
detect
small
chang
fev
fvc
specif
viral
infect
like
difficult
failur
detect
statist
signific
longterm
chang
pulmonari
function
viral
infect
interpret
proof
viral
infect
without
advers
effect
measur
midexpiratori
flow
rate
newer
test
function
small
airway
may
sensit
detect
effect
viral
infect
pulmonari
function
normal
adult
howev
test
appar
littl
valu
detect
chang
viral
infect
follow
cours
ill
patient
establish
obstruct
airway
thu
despit
recogn
difficulti
spirometr
test
investig
still
reli
measur
progress
copo
bate
describ
difficulti
assess
shortand
longterm
effect
environment
infecti
factor
cours
copo
comment
statist
handl
followup
data
kind
appear
rel
undevelop
scienc
art
explor
sever
approach
calcul
expect
valu
chang
pulmonari
function
individu
could
compar
observ
valu
direct
method
calcul
leastsquar
line
best
fit
individu
test
valu
durat
studi
method
sensit
acut
chang
function
expect
detect
longterm
chang
complex
method
calcul
expect
rate
declin
function
individu
deriv
equat
base
stepdown
regress
analysi
effect
independ
variabl
rate
declin
pulmonari
function
equat
abl
explain
observ
variat
individu
therefor
discard
qualit
result
variou
analys
quit
similar
acut
chang
pulmonari
function
seen
viral
infect
influenza
viral
infect
associ
greatest
acut
chang
convinc
evid
longterm
greater
six
month
chang
result
viral
infect
final
select
empir
random
method
estim
expect
valu
calcul
signific
conceptu
simplic
apprehens
assumpt
requir
wide
use
method
pair
rtest
sign
rank
test
deviat
regress
method
allow
us
compar
interv
surround
specif
viral
infect
control
interv
patient
thu
avoid
problem
vari
rate
declin
pulmonari
function
subject
differ
underli
diseas
note
control
interv
use
empir
random
analysi
select
free
infect
particular
viru
analysi
respiratori
ill
viral
infect
occur
throughout
control
interv
tri
separ
empir
random
analysi
simul
event
use
occur
sixmonth
interv
associ
known
viral
infect
analysi
led
somewhat
greater
differ
dr
mani
fewer
control
interv
avail
effect
statist
signific
arbitrari
hope
reason
choic
made
regard
specif
way
simul
approach
use
use
sixmonth
period
obtain
mean
pulmonari
function
event
interest
despit
use
threemonth
interv
event
felt
sixmonth
interv
would
lend
greater
stabil
baselin
measur
basi
statist
analysi
design
conserv
statist
signific
chang
fev
found
period
influenza
viral
infect
although
acut
chang
infect
parainfluenza
viru
respiratori
syncyti
viru
adenoviru
rhinoviru
statist
signific
elect
discuss
possibl
import
chang
consist
tion
advers
effect
small
number
observ
inher
variabl
spirometr
test
use
made
statist
analysi
subgroup
difficult
conclus
base
data
obtain
virusinfect
group
must
interpret
caution
investig
equat
infect
patient
copd
clinic
diagnosi
chest
ill
exacerb
gener
agre
respiratori
virus
frequent
caus
acut
respiratori
ill
patient
copd
pneumococc
h
influenza
infect
also
occasion
contribut
primari
secondari
invad
howev
least
ill
associ
known
infecti
agent
elect
studi
ill
associ
laboratoryproven
viral
infect
confin
analysi
specif
viral
infect
abl
demonstr
infect
influenza
virus
like
advers
effect
patient
copd
infect
common
respiratori
virus
common
respiratori
virus
influenza
virus
consist
infect
caus
histolog
abnorm
lower
respiratori
tract
therefor
surpris
found
influenza
viral
infect
associ
greatest
signific
chang
fev
fvc
acut
declin
ml
observ
influenza
viral
infect
similar
describ
johanson
smaller
acut
declin
fvc
fev
individu
associ
infect
parainfluenza
virus
virus
typic
affect
lower
respiratori
tract
primari
infect
childhood
wherea
reinfect
normal
adult
usual
confin
upper
respiratori
tract
gross
et
al
report
patient
copo
parainfluenza
viru
may
associ
viremia
persist
viru
pulmonari
secret
two
five
month
find
suggest
unusu
pathogen
potenti
viru
patient
copo
found
infect
respiratori
syncyti
viru
uncommon
patient
copo
observ
acut
advers
effect
infect
respiratori
syncyti
viru
patient
investig
suggest
respiratori
syncyti
viru
may
frequent
caus
acut
respiratori
ill
patient
copo
normal
adult
infect
rhinoviru
coronaviru
among
common
caus
acut
respiratori
ill
studi
except
subpopul
asthmat
rhinovir
infect
associ
appreci
advers
effect
fev
chang
fvc
rhinovir
infect
small
ml
statist
signific
transient
abnorm
function
small
airway
describ
normal
adult
rhinoviru
infect
indic
potenti
virus
invad
lower
respiratori
tract
note
cough
increas
sputum
product
often
associ
rhinovir
infect
spirometr
test
use
studi
detect
advers
effect
pulmonari
function
surpris
find
coronavirus
advers
effect
pulmonari
function
virus
even
less
damag
ciliat
tracheal
epitheli
cell
rhinovirus
accord
gump
et
al
herp
simplex
viru
may
associ
acut
exacerb
patient
copo
also
isol
viru
often
ill
asymptomat
interv
howev
unabl
detect
acut
chang
pulmonari
function
infect
herp
viru
analysi
rel
effect
influenza
viral
infect
differ
patient
subgroup
provid
data
although
statist
signific
often
consist
current
hypothes
pathogenesi
chronic
lung
diseas
subject
reactiv
airway
found
develop
somewhat
greater
declin
fev
l
influenza
viral
infect
whose
pulmo
smith
et
al
nari
function
improv
bronchodil
viru
infect
precipit
attack
asthma
empey
et
al
recent
shown
respiratori
tract
infect
presum
viral
increas
sensit
normal
lung
bronchospast
effect
histamin
nonspecif
irrit
data
consist
hypothesi
patient
hyperreact
airway
may
sensit
bronchospast
effect
viral
infect
smoke
associ
increas
rate
pulmonari
deterior
suscept
patient
underli
reactiv
airway
expect
confirm
report
fridi
et
al
smoker
experi
greater
advers
effect
viral
infect
lung
function
nonsmok
found
true
fev
l
fvc
three
month
influenza
viral
infect
also
observ
acut
chang
fev
greater
influenza
viral
infect
subject
abnorm
alphavantitrypsin
phenotyp
normal
phenotyp
possibl
combin
advers
effect
lowlevel
alphavantitrypsin
activ
infect
lung
function
suggest
mors
recent
report
analysi
associ
multipl
variabl
rate
declin
pulmonari
function
patient
popul
variabl
associ
rapid
rate
declin
includ
degre
exposur
cigarett
smoke
degre
airway
reactiv
frequenc
acut
lower
respiratori
tract
ill
unfortun
number
patient
suffici
permit
inclus
specif
viral
infect
multivari
analysi
abnorm
pulmonari
function
observ
viral
infect
respiratori
tract
patient
copo
transient
detect
period
infect
clinic
import
acut
transient
chang
depend
sever
underli
diseas
acut
viral
infect
patient
mild
co
po
alter
appreci
either
qualiti
durat
life
howev
acut
respiratori
ill
common
caus
death
studi
patient
co
po
report
diener
burrow
well
known
influenza
viral
infect
lethal
patient
chronic
lung
diseas
explan
appear
acut
fall
fvc
ml
toler
well
normal
adult
may
fatal
patient
advanc
copd
studi
group
whole
unabl
detect
longterm
greater
three
month
advers
effect
influenza
viral
infect
patient
copd
mark
longterm
abnorm
recent
describ
patient
recov
influenza
virusassoci
adult
respiratori
distress
syndrom
longterm
sequela
describ
influenza
viral
infect
children
inher
variabl
spirometr
test
use
must
temper
neg
result
studi
recognit
futur
studi
use
sensit
techniqu
larger
intens
studi
popul
may
ultim
demonstr
advers
longterm
effect
viral
infect
